Showing 141-150 of 8433 results for "".
Atopic Dermatitis Journal Club: AD Guidelines May Represent a ‘Paradigm Shift’ in Care
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/atopic-derm-journal-club-ad-guidelines-may-represent-a-paradigm-shift-in-care/24075/In the first video of this series, Derek Chu, MD and Peter Lio, MD talk about new atopic dermatitis (AD) guidelines from the American Academy of Allergy, Asthma and Immunology Joint Task Force. These guidelines potentially represent a reshaping of the approach to AD care and understanding, accordingHow Can Telemedicine Best Access the Inaccessible?
https://practicaldermatology.com/topics/practice-management/how-can-telemedicine-best-access-the-inaccessible/23954/Adam Friedman, MD, describes a new teledermatology program that brings care where it’s needed most.2019 Medical Aesthetic Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/2019-medical-aesthetic-trends/19696/What were the hot medical aesthetic trends of 2019 and what’s in the pipeline for 2020? Joel L. Cohen, MD weighs in.Antioxidants and Sunscreens
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-sunscreens--esapeged/19091/Jennifer Linder, MD, FAAD explains the science behind antioxidants in sunscreens and discusses the benefits of using antioxidants along with SPF.Emerging Therapies for AD
https://practicaldermatology.com/topics/atopic-dermatitis/emerging-therapies-for-ad/19639/Increased knowledge of the pathogenesis of AD has led to therapeutic advances for patients, says Emma Guttman, MD.Spectra Peel for Acne
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/spectra-peel/19522/Demonstration of SpectraPeel for acne and rejuvenation, using pulse and Q-switched modes. Presented by Kevin Deuplechain, MDAddressing the Unique Challenges of AD Patients
https://practicaldermatology.com/series/c-suite-chats/addressing-the-unique-challenges-of-ad-patients/28617/Patrick Burnett, MD, PhD, Chief Medical Officer at Arcutis Bioteheraputics, discusses the promise of the company’s roflumilast cream for AD.Dr. Simpson Highlights Potentially Remittive Anti-OX40s at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/dr-simpson-highlights-potentially-remittive-anti-ox40s-at-maui-derm/32920/Two anti-OX40 drugs in the pipeline may have remittive properties for atopic dermatitis, according to Eric Simpson, MD.The Acne Therapy Pipeline
https://practicaldermatology.com/topics/acne-rosacea/the-acne-therapy-pipeline/19724/From new agents to improved formulations, Lawrence Eichenfield, MD breaks down the latest advances in acne therapy.Nanotechnology Advances
https://practicaldermatology.com/topics/skin-cancer-photoprotection/nanotechnology-advances/19638/It’s time to pay attention to nanotechnology and how it’s being utilized in the OTC and Rx space, says Adam Friedman, MD.